Gabelli Funds’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.4M | Buy |
441,475
+6,400
| +1% | +$107K | 0.05% | 382 |
|
2025
Q1 | $6.69M | Buy |
435,075
+67,575
| +18% | +$1.04M | 0.05% | 386 |
|
2024
Q4 | $8.1M | Buy |
367,500
+183,000
| +99% | +$4.03M | 0.06% | 339 |
|
2024
Q3 | $3.32M | Buy |
184,500
+134,500
| +269% | +$2.42M | 0.02% | 548 |
|
2024
Q2 | $813K | Buy |
50,000
+18,000
| +56% | +$293K | 0.01% | 818 |
|
2024
Q1 | $452K | Hold |
32,000
| – | – | ﹤0.01% | 901 |
|
2023
Q4 | $334K | Hold |
32,000
| – | – | ﹤0.01% | 940 |
|
2023
Q3 | $326K | Sell |
32,000
-9,200
| -22% | -$93.8K | ﹤0.01% | 956 |
|
2023
Q2 | $310K | Sell |
41,200
-1,000
| -2% | -$7.53K | ﹤0.01% | 971 |
|
2023
Q1 | $373K | Sell |
42,200
-800
| -2% | -$7.08K | ﹤0.01% | 958 |
|
2022
Q4 | $392K | Sell |
43,000
-11,000
| -20% | -$100K | ﹤0.01% | 976 |
|
2022
Q3 | $436K | Sell |
54,000
-3,000
| -5% | -$24.2K | ﹤0.01% | 1007 |
|
2022
Q2 | $429K | Sell |
57,000
-2,000
| -3% | -$15.1K | ﹤0.01% | 1044 |
|
2022
Q1 | $554K | Hold |
59,000
| – | – | ﹤0.01% | 1025 |
|
2021
Q4 | $473K | Sell |
59,000
-4,000
| -6% | -$32.1K | ﹤0.01% | 1096 |
|
2021
Q3 | $614K | Sell |
63,000
-6,020
| -9% | -$58.7K | ﹤0.01% | 1012 |
|
2021
Q2 | $683K | Sell |
69,020
-3,000
| -4% | -$29.7K | ﹤0.01% | 987 |
|
2021
Q1 | $831K | Buy |
+72,020
| New | +$831K | 0.01% | 940 |
|
2019
Q3 | – | Sell |
-13,000
| Closed | -$120K | – | 1132 |
|
2019
Q2 | $120K | Buy |
+13,000
| New | +$120K | ﹤0.01% | 1094 |
|
2017
Q4 | – | Sell |
-20,000
| Closed | -$352K | – | 1118 |
|
2017
Q3 | $352K | Buy |
20,000
+5,000
| +33% | +$88K | ﹤0.01% | 1033 |
|
2017
Q2 | $498K | Sell |
15,000
-40,000
| -73% | -$1.33M | ﹤0.01% | 1005 |
|
2017
Q1 | $1.77M | Hold |
55,000
| – | – | 0.01% | 813 |
|
2016
Q4 | $1.99M | Hold |
55,000
| – | – | 0.01% | 784 |
|
2016
Q3 | $2.53M | Hold |
55,000
| – | – | 0.02% | 730 |
|
2016
Q2 | $2.76M | Hold |
55,000
| – | – | 0.02% | 715 |
|
2016
Q1 | $2.94M | Buy |
55,000
+5,000
| +10% | +$268K | 0.02% | 680 |
|
2015
Q4 | $3.28M | Buy |
50,000
+35,000
| +233% | +$2.3M | 0.02% | 633 |
|
2015
Q3 | $847K | Hold |
15,000
| – | – | 0.01% | 879 |
|
2015
Q2 | $887K | Sell |
15,000
-5,000
| -25% | -$296K | ﹤0.01% | 892 |
|
2015
Q1 | $1.25M | Hold |
20,000
| – | – | 0.01% | 846 |
|
2014
Q4 | $1.15M | Sell |
20,000
-1,000
| -5% | -$57.5K | 0.01% | 865 |
|
2014
Q3 | $1.13M | Hold |
21,000
| – | – | 0.01% | 865 |
|
2014
Q2 | $1.1M | Buy |
21,000
+6,000
| +40% | +$315K | 0.01% | 861 |
|
2014
Q1 | $793K | Hold |
15,000
| – | – | ﹤0.01% | 893 |
|
2013
Q4 | $601K | Hold |
15,000
| – | – | ﹤0.01% | 923 |
|
2013
Q3 | $567K | Hold |
15,000
| – | – | ﹤0.01% | 915 |
|
2013
Q2 | $588K | Buy |
+15,000
| New | +$588K | ﹤0.01% | 898 |
|